GRAL
Diagnostics & Research · Healthcare
Equibles does not estimate personal net worth.
Get an email with a short summary when GRAIL, Inc. publishes a filing, an earnings call transcript or a press release.
Get GRAL alertsGRAIL, Inc. reported in an 8-K filed June 24, 2024 that Josh Ofman was appointed President, effective June 21, 2024. The proxy statement of GRAIL, Inc. reports total compensation of $5,806,255 for Josh Ofman in fiscal 2024, including a base salary of $655,000. Disclosed compensation is on record for 2 fiscal years. Josh Ofman has spoken on 1 earnings call across 1 company, most recently for GRAIL, Inc. on November 4, 2026. GRAIL, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at GRAIL, Inc. includes Dr. Joshua Ofman (CEO), Joshua Ofman (CEO and Board Member), Robert P. Ragusa (CEO and Board Member) and 7 others.
“on June 21, 2024, the Board made the following officer appointments, effective immediately:”
“Good afternoon, everyone, and thank you for joining us to review results for the third quarter of 2026. and to discuss recent business updates.”
Proxy statement
Start not stated–present
Last confirmed April 15, 2025
GRAL
Diagnostics & Research · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | GRAIL, Inc. (GRAL) | President | $655,000 | $5,806,255 |
| 2023 | GRAIL, Inc. (GRAL) | President | $654,154 | $4,336,767 |